Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Konstantinos Loritis"'
Autor:
Alexandros Briasoulis, Christos Kourek, Adamantia Papamichail, Konstantinos Loritis, Dimitrios Bampatsias, Evangelos Repasos, Andrew Xanthopoulos, Elias Tsougos, Ioannis Paraskevaidis
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 10, Iss 8, p 337 (2023)
Cardiac amyloidosis (CA) is a rare but potentially life-threatening disease in which misfolded proteins accumulate in the cardiac wall tissue. Heart rhythm disorders in CA, including supraventricular arrhythmias, conduction system disturbances, or ve
Externí odkaz:
https://doaj.org/article/864d65b623674d668f8d24a91e3252a0
Autor:
Christos Kourek, Maria Touloupaki, Athanasios Rempakos, Konstantinos Loritis, Elias Tsougkos, Ioannis Paraskevaidis, Alexandros Briasoulis
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 9, Iss 8, p 259 (2022)
Cardiotoxicity is a significant complication of chemotherapeutic agents in cancer patients. Cardiovascular incidents including LV dysfunction, heart failure (HF), severe arrhythmias, arterial hypertension, and death are associated with high morbidity
Externí odkaz:
https://doaj.org/article/d2ae423e6bb0481e94c18a6f97d2d3d2
Autor:
Angeliki Chasouraki, Christos Kourek, Alexandros Sianis, Konstantinos Loritis, Peggy Kostakou, Elias Tsougos, Ioannis Paraskevaidis, Argyrios Ntalianis, Alexandros Briasoulis
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 9, Iss 5, p 158 (2022)
The therapeutical advances in recent years in the field of oncology treatment have increased survival rates and improved the quality of life of oncology patients, thus turning cancer into a chronic disease. However, most of the new cancer treatments
Externí odkaz:
https://doaj.org/article/8b477592d35a4b98baa1346ca12cce82
Autor:
Athanasios, Rempakos, Adamantia, Papamichail, Konstantinos, Loritis, Emmanouil, Androulakis, Nikki, Lama, Alexandros, Briasoulis
Publikováno v:
Current Pharmaceutical Design. 29:527-534
Abstract: Cardiac involvement is the leading cause of death in patients with cardiac amyloidosis. Early recognition is crucial as it can significantly change the course of the disease. Until now, the imaging modality of choice for diagnosing cardiac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b4afb78b9c7c925b2d1679419e8dbe8
https://doi.org/10.2174/1381612829666221212100114
https://doi.org/10.2174/1381612829666221212100114